Results 231 to 240 of about 16,806,898 (405)

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source

Optimizing patient engagement to enhance a learning health system. [PDF]

Front Health Serv
Mork M, Strilchuk A, Patel JN, Smith D, Wilkinson G, Brown A, Kromm S, Dyson M, Wasylak T.   +8 more
europepmc   +1 more source

Can We Improve the Monitoring of People With Multiple Sclerosis Using Simple Tools, Data Sharing, and Patient Engagement? [PDF]

, 2020
Kimberley Allen‐Philbey, Rod Middleton, Katie Tuite-Dalton, Elaine Baker, Andrea Stennett, Christo Albor, Klaus Schmierer   +6 more
openalex   +1 more source

Patient engagement in preclinical laboratory research: A scoping review

EBioMedicine, 2021
G. Fox, D. Fergusson, Z. Daham, M. Youssef, Madison Foster, Evelyn Poole, Ayni Sharif, D. Richards, K. Hendrick, A. Mendelson, Kimberly F. Macala, Zarah Monfaredi, J. Montroy, Kirsten M. Fiest, J. Presseau, M. Lalu   +15 more
semanticscholar   +1 more source

Strengthening international patient advocacy perspectives on patient involvement in HTA within the HTAi Patient and Citizen Involvement Interest Group – Commentary [PDF]

, 2017
Anna Mae Scott, Janet L. Wale, Neil Bertelsen, Nick Meade, null null   +4 more
core   +2 more sources

Complementarity of Long‐Reads and Optical Mapping in Parkinson's Disease for Structural Variants

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Long‐read sequencing and optical genome mapping technologies have the ability to detect large and complex structural variants. This has led to the discovery of novel pathogenic variants in neurodegenerative movement disorders. Thus, we aimed to systematically compare the SV detection capabilities of OGM and ONT in Parkinson's disease.
André Fienemann, Theresa Lüth, Susen Schaake, Carolin Gabbert, Marius Möller, Hauke Busch, Katja Lohmann, Jonas A. Gustafson, Danny E. Miller, Kensuke Daida, Manabu Funayama, Nobutaka Hattori, Samia Ben Sassi, Faycel Hentati, Matthew J. Farrer, Kristian K. Ullrich, Christine Klein, Joanne Trinh   +17 more
wiley   +1 more source

11 Essential together: a pan-Canadian program for the safe re-integration of essential care partners

BMJ Open Quality, 2022
Carol Fancott
doaj   +1 more source

Patient engagement in managed care pharmacy: Putting policy into practice. [PDF]

J Manag Care Spec Pharm
Vandigo J, Lenz K, Grace Tsiao E, Westrich K.   +3 more
europepmc   +1 more source

Engaging with patients [PDF]

BDJ Team, 2020
openaire   +1 more source

A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases

Arthritis Care &Research, EarlyView.
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah, Alexis Castellanos, Yen Chen, John Piette, Amy Bucher, Susan Murphy   +5 more
wiley   +1 more source